Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis-Reference-Cited by-同舟云学术

Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis

Published:2019-05-16 Issue:8 Volume:79 Page:875-886
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Scott Lesley J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-019-01135-8.pdf

Reference64 articles.

1. Faissner S, Gold R. Efficacy and safety of the newer multiple sclerosis drugs approved since 2010. CNS Drugs. 2018;32(3):269–87.

2. Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis: success from bench to bedside. Nat Rev Neurol. 2019;15(1):53–8.

3. Garnock-Jones KP. Teriflunomide: a review of its use in relapsing multiple sclerosis. CNS Drugs. 2013;27(12):1103–23.

4. European Medicines Agency. AUBAGIO (teriflunomide) 14 mg film-coated tablets: summary of product characteristics. 2018. http://www.ema.europa.eu/ . Accessed 31 Jan 2019.

5. Aly L, Hemmer B, Korn T. From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis. Curr Neuropharmacol. 2017;15(6):874–91.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teriflunomide, cognition and MRI: A longitudinal study;Multiple Sclerosis and Related Disorders;2024-10

2. Sclerosi multipla: trattamenti di base;EMC - Neurologia;2024-08

3. Mapping the Therapeutic Options for Multiple Sclerosis in Brazil: A Comprehensive Analysis;Sclerosis;2024-02-06

4. Synthesis of Trifluoromethylated Monoterpenes by an Engineered Cytochrome P450;Chemistry – A European Journal;2024-01-03

5. Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo;Frontiers in Cellular and Infection Microbiology;2023-12-19